Herpes zoster risk factors

Jump to navigation Jump to search

Herpes zoster Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Herpes zoster from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Herpes Zoster
Congenital Varicella Syndrome

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Herpes zoster risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Herpes zoster risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Herpes zoster risk factors

CDC on Herpes zoster risk factors

Herpes zoster risk factors in the news

Blogs on Herpes zoster risk factors

Directions to Hospitals Treating Herpes zoster

Risk calculators and risk factors for Herpes zoster risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; L. Katie Morrison, MD; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Risk Factors

Only people who were previously infected with VZV (through natural infection that caused varicella or varicella vaccination) can develop shingles. Although many people do not remember, approximately 99.5% of people born in the United States who are 40 years of age and older have had varicella. As a result, all older adults in the United States are at risk for herpes zoster.

The reasons why VZV reactivates and causes herpes zoster are not well understood. However, a person's risk for herpes zoster may increase as their VZV-specific cell-mediated immunity declines. This decline in immunity can result from increasing age and/or immunosuppressive medical conditions and medications.

A person's risk for herpes zoster increases sharply after 50 years of age. About 50% of people who live to 85 years of age will have had an episode of herpes zoster. A person’s risk for PHN also increases sharply with age. The oldest adults with herpes zoster are most likely to be hospitalized for complications from the disease and to develop PHN.

People with compromised or suppressed immune systems who have an increased risk for herpes zoster include those:

  • with cancer, especially leukemia and lymphoma,
  • with human immunodeficiency virus,
  • who have undergone bone marrow or solid organ (renal, cardiac, liver, and lung) transplantation, or
  • who are taking immunosuppressive medications, including steroids, chemotherapy, or transplant-related immunosuppressive medications.

Other potential risk factors for herpes zoster have been identified but the findings are not consistent in all studies. For example-

  • Some studies found that more women than men develop herpes zoster, but other studies did not find a difference [1][2]; the reason for a possible difference between women and men is not known.
  • Some studies conducted in the United States and elsewhere found that herpes zoster is less common in African Americans (by at least 50%) than in whites[3].

References

  1. Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) (2008). "Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep. 57 (RR-5): 1–30, quiz CE2-4. PMID 18528318.
  2. Thomas SL, Hall AJ (2004). "What does epidemiology tell us about risk factors for herpes zoster?". Lancet Infect Dis. 4 (1): 26–33. PMID 14720565.
  3. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ (2011). "Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease". JAMA. 305 (2): 160–6. doi:10.1001/jama.2010.1983. PMID 21224457.


Template:WikiDoc Sources